Skip to main content
. 2021 Oct;17(10):468–475.

Table 2.

Disorders of Esophagogastric Junction Outflow

Achalasia
  • Type I: Abnormal IRP and absent contractility (100% failed peristalsis)

  • Type II: Abnormal IRP and absent contractility with panesophageal pressurization in 20% or more swallows

  • Type III: Abnormal IRP and evidence of spasm (20% or more swallows with premature contraction) with no peristalsis

  • Cutoff of spasm in 20% of swallows is arbitrary; confidence for Type III achalasia is increased with higher number of premature swallows

  • Inconclusive diagnosis of achalasia is best resolved with a TBE with a 13-mm barium tablet and/or FLIP in patients with dysphagia

  • Opioids are associated with Type III achalasia, and patients should be studied off opioid medication, if possible. Timing of discontinuation is based on drug half-life

EGJOO
  • Manometric diagnosis of EGJOO is always considered clinically inconclusive

  • Manometric diagnosis requires an elevated median IRP in both the supine and upright positions, increased intrabolus pressure, and evidence of peristalsis

  • Clinically relevant symptoms of EGJOO include dysphagia (usually solid foods) and/or noncardiac chest pain

  • Definitive diagnosis of EGJOO requires supportive evidence of obstruction by TBE with a barium tablet and/or FLIP

Bold text indicates important new criteria in Chicago Classification version 4.0.

EGJOO, esophagogastric junction outflow obstruction; FLIP, functional lumen imaging planimetry; IRP, integrated relaxation pressure; TBE, timed barium esophagram.